Solara Active Pharma Sciences Limited
NSE:SOLARA.NS
502.5 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 84.4 | 87.3 | 463.8 | 1,976.9 | 560.4 | 757.21 | 459.52 | 0.1 |
| Short Term Investments
| 0 | 133.9 | 104 | 286.2 | 152.1 | -695.12 | -497.69 | 0 |
| Cash and Short Term Investments
| 84.4 | 221.2 | 463.8 | 1,976.9 | 560.4 | 757.21 | 459.52 | 0.1 |
| Net Receivables
| 3,485.2 | 5,369.9 | 4,896.7 | 4,838.7 | 2,265.3 | 2,888 | 2,625.2 | 0 |
| Inventory
| 3,597 | 5,580.9 | 5,755.5 | 2,949.7 | 2,797.3 | 2,204.03 | 1,876.6 | 0 |
| Other Current Assets
| 840.9 | 837.3 | 1,276.8 | 811 | 1,096.9 | 527.4 | 946.41 | 0 |
| Total Current Assets
| 8,007.5 | 11,873.2 | 12,392.8 | 10,576.3 | 6,719.9 | 6,545.53 | 6,078.11 | 0.1 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 11,142.2 | 11,590.5 | 11,601.2 | 10,388.6 | 9,649.8 | 7,739.57 | 7,036.07 | 0 |
| Goodwill
| 3,650.9 | 3,650.9 | 3,650.9 | 3,650.9 | 3,650.9 | 3,586.3 | 3,585.71 | 0 |
| Intangible Assets
| 425.6 | 543.5 | 679.4 | 799.8 | 922.8 | 1,028.71 | 1,007.74 | 0 |
| Goodwill and Intangible Assets
| 4,076.5 | 4,194.4 | 4,330.3 | 4,450.7 | 4,573.7 | 4,615.01 | 4,593.45 | 0 |
| Long Term Investments
| 17 | 17 | 4.2 | 4.2 | 3.2 | 699.25 | 505.81 | 0 |
| Tax Assets
| 0 | 785.6 | 551.4 | 256.1 | 0.7 | 0.65 | 0.65 | 0 |
| Other Non-Current Assets
| 266.4 | 529.9 | 645.4 | 459.9 | 587.7 | 0.38 | 1.24 | 0 |
| Total Non-Current Assets
| 15,502.1 | 17,117.4 | 17,132.5 | 15,559.5 | 14,815.1 | 13,054.86 | 12,137.22 | 0 |
| Total Assets
| 23,509.6 | 28,990.6 | 29,525.3 | 26,135.8 | 21,535 | 19,600.39 | 18,215.33 | 0.1 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 3,130.1 | 3,058.6 | 2,759.9 | 3,092.9 | 2,161.2 | 2,443.8 | 3,128.73 | 0.033 |
| Short Term Debt
| 8,940.6 | 7,666 | 7,436.3 | 4,541.3 | 4,764.9 | 3,130.9 | 3,600.25 | 0 |
| Tax Payables
| 0.1 | 0.1 | 3.3 | 1.4 | 0.084 | 28.5 | 35.06 | 0 |
| Deferred Revenue
| 41.9 | 160.1 | 384 | 202.9 | 319.5 | 928.41 | 301.59 | 0 |
| Other Current Liabilities
| 315.8 | 212.3 | 254.9 | 110.9 | 188.616 | 711.8 | 12.27 | 0 |
| Total Current Liabilities
| 12,428.5 | 11,009 | 10,709.9 | 7,887.5 | 7,298.9 | 6,554.95 | 7,379.49 | 0.033 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 1,174.4 | 2,462.5 | 2,937.4 | 1,666 | 2,454.7 | 2,339.2 | 2,466.72 | 0 |
| Deferred Revenue Non-Current
| 0 | -833.1 | 231.3 | 284.9 | 427.4 | 569.92 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 833.1 | -132.2 | -167.1 | 118.3 | 328.25 | 484.32 | 0 |
| Other Non-Current Liabilities
| 540.9 | 494.5 | 374.9 | 369.8 | 333.4 | 1,103.8 | 200.22 | 0 |
| Total Non-Current Liabilities
| 1,715.3 | 2,957 | 3,543.6 | 2,320.7 | 3,333.8 | 3,442.98 | 3,151.26 | 0 |
| Total Liabilities
| 14,143.8 | 13,966 | 14,253.5 | 10,208.2 | 10,632.7 | 9,997.93 | 10,530.75 | 0.033 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 15,013.5 | 15,257.5 | 0 | 12,613.8 | 0 | 0 | 0 |
| Common Stock
| 360 | 360 | 360 | 359.2 | 268.5 | 257.74 | 246.74 | 0 |
| Retained Earnings
| -3,175.2 | 2,493.1 | 2,737.2 | 3,388.5 | 1,397 | 445.81 | -42.41 | -0.033 |
| Accumulated Other Comprehensive Income/Loss
| -6 | -11.3 | -8.8 | 20.3 | -1,754.4 | -929.84 | -261.5 | 0.1 |
| Other Total Stockholders Equity
| 12,160.3 | 12,160.3 | 12,160.3 | 12,117.1 | 8,205.5 | 7,806.1 | 7,434.83 | 0 |
| Total Shareholders Equity
| 9,339.1 | 15,002.2 | 15,248.7 | 15,885.2 | 10,859.4 | 9,558.68 | 7,639.78 | 0.067 |
| Total Equity
| 9,365.8 | 15,024.6 | 15,271.8 | 15,927.6 | 10,902.3 | 9,602.46 | 7,684.58 | 0.067 |
| Total Liabilities & Shareholders Equity
| 23,509.6 | 28,990.6 | 29,525.3 | 26,135.8 | 21,535 | 19,600.39 | 18,215.33 | 0.1 |